Benzinga | Jul 14, 2020 11:17AM EDT

BWS Financial Initiates Coverage On Collegium Pharmaceutical with Sell Rating, Announces Price Target of $8

BWS Financial initiates coverage on Collegium Pharmaceutical (NASDAQ:COLL) with a Sell rating and announces Price Target of $8.